Deuterium Capital Management LLC Lowers Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Deuterium Capital Management LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 15,425 shares of the medical equipment provider’s stock after selling 7,575 shares during the quarter. Intuitive Surgical comprises about 21.1% of Deuterium Capital Management LLC’s portfolio, making the stock its 2nd biggest holding. Deuterium Capital Management LLC’s holdings in Intuitive Surgical were worth $8,051,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of ISRG. State Street Corp increased its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. FMR LLC boosted its holdings in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC raised its holdings in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after buying an additional 86,488 shares in the last quarter. Finally, Baillie Gifford & Co. lifted its position in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 12,598 shares of company stock worth $7,223,467. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $557.96 on Wednesday. The firm has a market cap of $198.73 billion, a P/E ratio of 87.05, a P/E/G ratio of 5.85 and a beta of 1.39. The stock’s 50 day moving average is $571.08 and its 200 day moving average is $530.63. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Analysts Set New Price Targets

A number of research analysts have issued reports on ISRG shares. Truist Financial lifted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Royal Bank of Canada increased their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.